characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-09-0037-1_Visit 3

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 3


status: PUBLIC

text: Systems Immunology/Bioinformatics, Benaroya Research Institute at Virginia Mason

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

tag: attribute

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-06-0065-5_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

characteristic: treatment

text: Visit 14

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-08-0100-7_Visit 14

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: Homo sapiens

text: Nasal Lavage

text: 30-06-0058-9_Visit 14

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 14


text: live

text: Generic

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-10-0101-3_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-09-0039-3_Visit 14

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 14

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-03-0016-5_Visit 14

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-07-0045-2_Visit 14

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-10-0034-2_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: 30-06-0014-7_Visit 14

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 14

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-07-0031-8_Visit 14

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: 30-04-0009-6_Visit 14

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: 30-04-0019-7_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-05-0014-6_Visit 14

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 14

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-02-0012-0_Visit 14

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-08-0035-0_Visit 14

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-09-0027-0_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-05-0034-9_Visit 14

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 14

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-02-0005-9_Visit 14

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-08-0099-8_Visit 14

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-06-0056-7_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: 30-10-0075-1_Visit 14

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 14

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-07-0029-4_Visit 14

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: 30-04-0018-6_Visit 14

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: 30-04-0011-1_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-04-0013-3_Visit 14

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 14

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-10-0024-3_Visit 14

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-10-0004-0_Visit 14

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-05-0013-5_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-03-0009-7_Visit 14

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 14

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-03-0007-5_Visit 14

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-09-0026-4_Visit 14

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-09-0019-1_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: Completed Study

text: Placebo

characteristic: treatment

text: Randomization

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Randomization


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: Discontinued Study

characteristic: time in study in years

text: Placebo

text: Randomization


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: Discontinued Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Randomization


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CDNDKANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-10-0082-5_Visit 3

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CDNDKANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-10-0060-6_Visit 3

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CDNDKANXX

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-07-0033-5_Visit 3

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CDNDKANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-07-0034-6_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CDNDKANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-07-0032-9_Visit 3

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CDNDKANXX

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-07-0029-4_Visit 3

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CDNDKANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-02-0017-7_Visit 3

text: Discontinued Study

characteristic: time in study in years

text: Placebo

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CDNDKANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-03-0012-1_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CDNDKANXX

text: Homo sapiens

text: Nasal Lavage

text: 30-06-0023-5_Visit 3

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 3

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CDNDKANXX

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-08-0035-0_Visit 3

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CDNDKANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: 30-08-0039-4_Visit 3

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CDNDKANXX

text: Homo sapiens

text: Nasal Lavage

text: 30-08-0019-2_Visit 3

text: Discontinued Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CDNDKANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-05-0013-5_Visit 3

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CDNDKANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-06-0015-0_Visit 3

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CDNDKANXX

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-07-0025-0_Visit 3

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CDNDKANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-02-0013-1_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CDNDKANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-02-0011-4_Visit 3

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CDNDKANXX

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-10-0024-3_Visit 3

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CDNDKANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-09-0023-8_Visit 3

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CDNDKANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-09-0027-0_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CDNDKANXX

text: Homo sapiens

text: Nasal Lavage

text: 30-04-0003-4_Visit 3

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 3

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CDNDKANXX

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-06-0024-6_Visit 3

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CDNDKANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: 30-10-0071-8_Visit 3

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CDNDKANXX

text: Homo sapiens

text: Nasal Lavage

text: 30-07-0035-1_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CDNDKANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-07-0031-8_Visit 3

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CDNDKANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-09-0026-4_Visit 3

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CDNDKANXX

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-08-0024-8_Visit 3

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CDNDKANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-05-0011-8_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CDNDKANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-02-0016-6_Visit 3

text: Discontinued Study

text: Mepolizumab

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CDNDKANXX

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-04-0019-7_Visit 3

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CDNDKANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-03-0008-6_Visit 3

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CDNDKANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-06-0021-8_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CDNDKANXX

text: Homo sapiens

text: Nasal Lavage

text: 30-07-0027-2_Visit 3

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 3

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CDNDKANXX

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-02-0012-0_Visit 3

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CDNDKANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: 30-02-0008-7_Visit 3

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CDNDKANXX

text: Homo sapiens

text: Nasal Lavage

text: 30-08-0016-4_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CDNDKANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-10-0040-2_Visit 3

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CDNDKANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-10-0023-2_Visit 3

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CDNDKANXX

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-09-0022-7_Visit 3

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CDNDKANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-06-0002-6_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CDNDKANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-04-0002-3_Visit 3

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CDNDKANXX

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-06-0002-6_Visit 14

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CDNDKANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Randomization


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CDNDKANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Randomization


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CDNDKANXX

text: Homo sapiens

text: Nasal Lavage

text: Discontinued Study

text: Placebo

characteristic: treatment

text: Randomization

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CDNDKANXX

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: Discontinued Study

characteristic: study id

text: Mepolizumab

text: Randomization


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: 30-07-0028-3_Visit 3

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: 30-08-0017-0_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-08-0009-1_Visit 3

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-05-0008-3_Visit 3

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-07-0014-8_Visit 3

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-07-0009-2_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-08-0025-4_Visit 3

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-06-0012-5_Visit 3

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-08-0003-9_Visit 3

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-05-0007-2_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: 30-09-0017-4_Visit 3

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 3

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-02-0001-0_Visit 3

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: 30-05-0008-3_Visit 14

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: 30-05-0002-5_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-05-0004-7_Visit 14

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 14

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-06-0016-1_Visit 14

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-06-0009-3_Visit 14

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-10-0020-4_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-07-0014-8_Visit 14

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 14

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-07-0019-3_Visit 14

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-07-0016-0_Visit 14

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-07-0012-6_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: 30-07-0009-2_Visit 14

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 14

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-07-0005-3_Visit 14

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: 30-07-0003-8_Visit 14

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: 30-02-0007-6_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-02-0002-1_Visit 14

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 14

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-08-0017-0_Visit 14

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-08-0009-1_Visit 14

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-09-0020-5_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-09-0014-5_Visit 14

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 14

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-09-0002-9_Visit 14

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-09-0008-4_Visit 14

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-09-0006-2_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: 30-03-0002-2_Visit 14

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 14

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-05-0009-4_Visit 14

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: 30-05-0007-2_Visit 14

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: 30-05-0003-6_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-06-0012-5_Visit 14

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 14

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-06-0005-4_Visit 14

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-06-0004-8_Visit 14

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-10-0026-5_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-10-0016-9_Visit 14

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 14

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-07-0015-4_Visit 14

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-07-0018-2_Visit 14

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-07-0013-7_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: 30-07-0004-9_Visit 14

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 14

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-07-0010-9_Visit 14

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: 30-07-0008-1_Visit 14

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: 30-07-0001-6_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-02-0005-9_Visit 14

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 14

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-02-0001-0_Visit 14

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-08-0013-8_Visit 14

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-08-0003-9_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-09-0007-3_Visit 14

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 14

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-09-0015-2_Visit 14

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-09-0016-3_Visit 14

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-09-0017-4_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: 30-09-0003-5_Visit 14

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 14

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-09-0010-6_Visit 14

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 14


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: 30-03-0003-3_Visit 14

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 14


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Homo sapiens

text: Nasal Lavage

text: 30-03-0001-1_Visit 14

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 14


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Randomization

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: Completed Study

characteristic: study id

text: Placebo

text: Randomization


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-06-0008-2_Visit 3

text: Discontinued Study

characteristic: time in study in years

text: Placebo

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-03-0003-3_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-09-0016-3_Visit 3

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-10-0026-5_Visit 3

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-05-0003-6_Visit 3

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-07-0008-1_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

text: Nasal Lavage

text: 30-09-0006-2_Visit 3

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 3

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-03-0002-2_Visit 3

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: 30-07-0019-3_Visit 3

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

text: Nasal Lavage

text: 30-05-0002-5_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-06-0006-0_Visit 3

text: Discontinued Study

text: Mepolizumab

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-07-0005-3_Visit 3

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-09-0008-4_Visit 3

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-03-0001-1_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-09-0007-3_Visit 3

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-09-0020-5_Visit 3

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-07-0016-0_Visit 3

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-07-0004-9_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

text: Nasal Lavage

text: 30-06-0004-8_Visit 3

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 3

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-04-0013-3_Visit 3

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: 30-02-0005-9_Visit 3

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

text: Nasal Lavage

text: 30-09-0019-1_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-07-0018-2_Visit 3

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-09-0003-5_Visit 3

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-06-0005-4_Visit 3

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-07-0003-8_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-04-0007-9_Visit 3

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-02-0002-1_Visit 3

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-10-0016-9_Visit 3

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-07-0015-4_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

text: Nasal Lavage

text: 30-06-0002-6_Visit 3

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 3

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-07-0001-6_Visit 3

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: 30-08-0013-8_Visit 3

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

text: Nasal Lavage

text: 30-05-0009-4_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-06-0009-3_Visit 3

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-09-0015-2_Visit 3

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-07-0013-7_Visit 3

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-09-0002-9_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Placebo

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-04-0004-0_Visit 3

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-02-0001-0_Visit 3

text: Completed Study

characteristic: study id

text: Mepolizumab

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-08-0002-8_Visit 3

text: Discontinued Study

characteristic: time in study in years

text: Placebo

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-05-0008-3_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

text: Nasal Lavage

text: 30-02-0007-6_Visit 3

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Visit 3

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-06-0011-9_Visit 3

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: 30-09-0014-5_Visit 3

text: Completed Study

characteristic: time in study in years

text: Placebo

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

text: Nasal Lavage

text: 30-07-0012-6_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-04-0003-4_Visit 3

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

characteristic: percent aligned

text: Nasal Lavage

text: 30-02-0003-2_Visit 3

text: Discontinued Study

characteristic: study id

text: Placebo

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-06-0016-1_Visit 3

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

text: 30-10-0020-4_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-05-0004-7_Visit 3

text: Completed Study

text: Placebo

characteristic: treatment

text: Visit 3

characteristic: visit


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: 30-07-0010-9_Visit 3

text: Completed Study

characteristic: study id

text: Placebo

text: Visit 3


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

text: Nasal Lavage

characteristic: source tissue

text: 30-09-0010-6_Visit 3

text: Completed Study

characteristic: time in study in years

text: Mepolizumab

text: Visit 3


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

text: 30-04-0002-3_Visit 3

text: Completed Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Visit 3


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

text: Nasal Lavage

text: Completed Study

text: Mepolizumab

characteristic: treatment

text: Randomization

characteristic: visit


text: live

text: Generic

characteristic: SRA accession

characteristic: aligned counts in millions

characteristic: exacerbation number

characteristic: fastq total reads

text: CCHDTANXX

characteristic: flowcell id

text: Homo sapiens

characteristic: percent aligned

text: Nasal Lavage

text: Completed Study

characteristic: study id

text: Placebo

text: Randomization


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: CCHDTANXX

characteristic: median cv coverage

text: Homo sapiens

characteristic: organism

text: Nasal Lavage

characteristic: source tissue

text: Discontinued Study

characteristic: time in study in years

text: Placebo

text: Randomization


characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: CCHDTANXX

text: Homo sapiens

text: Nasal Lavage

text: Discontinued Study

characteristic: status

characteristic: title

text: Mepolizumab

text: Randomization


W25K Chromosome

text: Hunan Normal University

text: live

text: Microbe, viral or environmental

characteristic: collection date

text: China

characteristic: geo loc name

text: pig

characteristic: host

text: LB medium

text: 28 N 112 E

characteristic: lat lon

text: Escherichia coli

text: Gut E. coli strains variation could affect pig adaptation

text: cell culture

characteristic: sample type

characteristic: strain

text: Microbe sample from Escherichia coli


characteristic: External Id

text: Zhejiang University

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: MIGS.eu

characteristic: SRA accession

text: parasite

text: hemocyte of Pxy parasitized by Cve 1h post parasitization

characteristic: description

text: ZJU

characteristic: ecotype

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 1

characteristic: replicate


text: Zhejiang University

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: MIGS.eu

characteristic: NCBI submission model

text: parasite

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

characteristic: organism

text: replicate = biological replicate 2


text: Zhejiang University

text: live

text: MIGS.eu

characteristic: NCBI submission package

text: parasite

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 3

characteristic: title


text: Zhejiang University

text: live

text: MIGS.eu

text: parasite

text: hemocyte of Pxy parasitized by Cve 6h post parasitization

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 1


text: Zhejiang University

text: live

text: MIGS.eu

text: parasite

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 2


text: Zhejiang University

text: live

text: MIGS.eu

text: parasite

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 3


text: Zhejiang University

text: live

text: MIGS.eu

text: parasite

text: hemocyte of Pxy parasitized by Cve 12h post parasitization

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 1


text: Zhejiang University

text: live

text: MIGS.eu

text: parasite

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 2


text: Zhejiang University

text: live

text: MIGS.eu

text: parasite

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 3


text: Zhejiang University

text: live

text: MIGS.eu

text: parasite

text: hemocyte of Pxy parasitized by Cve 24h post parasitization

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 1


text: Zhejiang University

text: live

text: MIGS.eu

text: parasite

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 2


text: Zhejiang University

text: live

text: MIGS.eu

text: parasite

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 3


text: Zhejiang University

text: live

text: MIGS.eu

text: parasite

text: hemocyte of Pxy parasitized by Cve 72h post parasitization

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 1


text: Zhejiang University

text: live

text: MIGS.eu

text: parasite

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 2


text: Zhejiang University

text: live

text: MIGS.eu

text: parasite

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 3


text: Zhejiang University

text: live

text: MIGS.eu

text: parasite

text: hemocyte of Pxy parasitized by Cve 120h post parasitization

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 1


text: Zhejiang University

text: live

text: MIGS.eu

text: parasite

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 2


text: Zhejiang University

text: live

text: MIGS.eu

text: parasite

text: ZJU

text: Rearing in laboratory

text: laboratory

text: not applicable

text: China: Hangzhou

text: laboratory

text: 30.3009 N 120.0870 E

text: Plutella xylostella

text: replicate = biological replicate 3


Shewanella sp. strain SM102_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

characteristic: depth

text: Keywords: GSC:MIxS;MIGS:5.0

characteristic: elev

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: low density polyethylene (LPDE) from waste management plant

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM102

text: manuscript in preparation

text: Shewanella sp. strain SM102


Shewanella sp. strain SM101_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM101

text: manuscript in preparation

characteristic: strain

text: Shewanella sp. strain SM101


Shewanella sp. strain SM103_NP

characteristic: External Id

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM103

text: manuscript in preparation

text: Shewanella sp. strain SM103


Shewanella sp. strain SM20_NP

text: AgResearch

characteristic: INSDC center name

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM20

text: manuscript in preparation

text: Shewanella sp. strain SM20


Shewanella sp. strain SM21_NP

text: AgResearch

characteristic: INSDC first public

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM21

text: manuscript in preparation

text: Shewanella sp. strain SM21


Shewanella sp. strain SM23_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

characteristic: SRA accession

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM23

text: manuscript in preparation

text: Shewanella sp. strain SM23


Shewanella sp. strain SM29_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

characteristic: description

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM29

text: manuscript in preparation

text: Shewanella sp. strain SM29


Shewanella sp. strain SM32_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM32

text: manuscript in preparation

text: Shewanella sp. strain SM32


Shewanella sp. strain SM34_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM34

text: manuscript in preparation

text: Shewanella sp. strain SM34


Shewanella sp. strain SM35_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM35

text: manuscript in preparation

text: Shewanella sp. strain SM35


Shewanella sp. strain SM43_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM43

text: manuscript in preparation

text: Shewanella sp. strain SM43


Shewanella sp. strain SM55_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM55

text: manuscript in preparation

text: Shewanella sp. strain SM55


Shewanella sp. strain SM65_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM65

text: manuscript in preparation

text: Shewanella sp. strain SM65


Shewanella sp. strain SM68_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM68

text: manuscript in preparation

text: Shewanella sp. strain SM68


Shewanella sp. strain SM69_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM69

text: manuscript in preparation

text: Shewanella sp. strain SM69


Shewanella sp. strain SM71_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM71

text: manuscript in preparation

text: Shewanella sp. strain SM71


Shewanella sp. strain SM72_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM72

text: manuscript in preparation

text: Shewanella sp. strain SM72


Shewanella sp. strain SM73_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM73

text: manuscript in preparation

text: Shewanella sp. strain SM73


Shewanella sp. strain SM74_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM74

text: manuscript in preparation

text: Shewanella sp. strain SM74


Shewanella sp. strain SM77_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella glacialipiscicola

text: manuscript in preparation

text: Shewanella sp. strain SM77


Shewanella sp. strain SM78_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM78

text: manuscript in preparation

text: Shewanella sp. strain SM78


Shewanella sp. strain SM87_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM87

text: manuscript in preparation

text: Shewanella sp. strain SM87


Shewanella sp. strain SM91_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella glacialipiscicola

text: manuscript in preparation

text: Shewanella sp. strain SM91


Shewanella sp. strain SM95_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM95

text: manuscript in preparation

text: Shewanella sp. strain SM95


Shewanella sp. strain SM96_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SM96

text: manuscript in preparation

text: Shewanella sp. strain SM96


Shewanella sp. strain SW1_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SW1

text: manuscript in preparation

text: Shewanella sp. strain SW1


Shewanella sp. strain SW24_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SW24

text: manuscript in preparation

text: Shewanella sp. strain SW24


Shewanella sp. strain SW29_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SW29

text: manuscript in preparation

text: Shewanella sp. strain SW29


Shewanella sp. strain SW32_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SW32

text: manuscript in preparation

text: Shewanella sp. strain SW32


Shewanella sp. strain SW36_NP

text: AgResearch

text: live

text: MIGS/MIMS/MIMARKS.microbial

text: MIGS.ba

text: Keywords: GSC:MIxS;MIGS:5.0

text: waste management plant

text: plasitcs

text: low density polyethylene (LPDE)

text: New Zealand

text: liquid ASTM medium

text: 40.3545 S 175.6097 E

text: unknown

text: Shewanella sp. SW36

text: manuscript in preparation

text: Shewanella sp. strain SW36